PT Metro Healthcare Indonesia Tbk

IDX:CARE Stock Report

Market Cap: Rp4.4t

Metro Healthcare Indonesia Past Earnings Performance

Past criteria checks 0/6

Metro Healthcare Indonesia's earnings have been declining at an average annual rate of -53.4%, while the Healthcare industry saw earnings growing at 3.7% annually. Revenues have been growing at an average rate of 8% per year.

Key information

-53.4%

Earnings growth rate

-39.4%

EPS growth rate

Healthcare Industry Growth14.1%
Revenue growth rate8.0%
Return on equity-2.9%
Net Margin-29.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Metro Healthcare Indonesia makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

IDX:CARE Revenue, expenses and earnings (IDR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24308,717-89,386118,6460
30 Jun 24301,357-116,151124,6510
31 Mar 24271,522-100,908117,2880
31 Dec 23242,681-110,920116,3220
30 Sep 23260,242-104,612126,1900
30 Jun 23254,536-81,944126,0820
31 Mar 23251,761-104,203139,0360
31 Dec 22260,426-93,544145,8210
30 Sep 22230,153-92,420134,0300
30 Jun 22257,336-61,350132,2190
31 Mar 22278,751-25,135127,9140
31 Dec 21290,9346,099121,6070
30 Sep 21289,79921,958128,4940
30 Jun 21258,20123,746125,3170
31 Mar 21234,68624,829118,8940
31 Dec 20216,29614,313113,6050
30 Sep 20198,3308,81197,6150
30 Jun 20214,832-3,90795,0100
31 Mar 20186,776-17,92979,6050
31 Dec 19154,077-24,20564,4390
31 Dec 1887,209-27,48738,2790
31 Dec 1731,198-11,51912,8420

Quality Earnings: CARE is currently unprofitable.

Growing Profit Margin: CARE is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CARE is unprofitable, and losses have increased over the past 5 years at a rate of 53.4% per year.

Accelerating Growth: Unable to compare CARE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CARE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (2.7%).


Return on Equity

High ROE: CARE has a negative Return on Equity (-2.94%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies